Cost-effectiveness in the treatment of schizophrenia
Author:
- 1 January 1996
- journal article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 11 (3) , 137-143
Abstract
Summary: This paper discusses the need for a health economics perspective and some of the central methodological issues raised by economic appraisals, including cost-effectiveness and cost-utility analyses. It illustrates how cost-effectiveness studies can inform policy and practice decisions concerning the treatment of schizophrenia, focusing on five generic evaluation questions commonly raised. Examples are drawn from recent and current UK research.Keywords
This publication has 22 references indexed in Scilit:
- Home-Based Versus Hospital-Based Care for People with Serious Mental IllnessThe British Journal of Psychiatry, 1994
- Community Psychiatric Nurse Teams: Cost-effectiveness of Intensive Support Versus Generic CareThe British Journal of Psychiatry, 1994
- A Controlled Trial of Home-Based Acute Psychiatric ServicesThe British Journal of Psychiatry, 1993
- Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United KingdomThe British Journal of Psychiatry, 1993
- Psychopharmacology and the Ethics of Resource AllocationThe British Journal of Psychiatry, 1993
- QALYs in mental health: a case studyPsychological Medicine, 1992
- Social services assessment and care management: Getting it rightJournal of Mental Health, 1992
- Current practice in obtaining the "Q" in QALYs: a cautionary note.BMJ, 1991
- QALYs in psychiatric care?Psychiatric Bulletin, 1990
- The economic burden of schizophreniaPsychiatric Bulletin, 1990